人福医药集团股份公司关于公司持股5%以上股东承诺履行完毕的公告

Core Viewpoint - The announcement details the completion of a share acquisition by Yichang Chuantou Holdings Group Co., Ltd. (Yichang Chuantou) of Wuhu Xinfeng Equity Investment Partnership (Limited Partnership), indicating a significant corporate restructuring and consolidation of control [1][2]. Group 1 - Yichang Chuantou's commitment to acquire all shares of Wuhu Xinfeng from China Cinda Asset Management Co., Ltd. and Xinsonglibao Equity Investment Co., Ltd. is set to be fulfilled by December 31, 2025 [1]. - On October 29, 2025, Yichang Chuantou's wholly-owned subsidiary completed the acquisition and delivery of all shares of Wuhu Xinfeng, achieving full control over the entity [2]. - The completion of this acquisition signifies the fulfillment of Yichang Chuantou's related commitments [2].